View Older Stories View More Recent Stories

Apr 8, 2026 10:15AM Arcline-Backed Arxis Announces Launch of its Initial Public Offering
Apr 8, 2026 08:12AM Defense supplier Arxis seeks to raise up to $1.06 billion in Nasdaq IPO
Apr 8, 2026 07:01AM Arxis launches IPO offering 37.7 million shares at $25-$28 each
Apr 8, 2026 07:00AM Arxis Announces Launch of its Initial Public Offering
Apr 7, 2026 04:05PM Arista Networks to Announce Q1 2026 Financial Results on Tuesday, May 5, 2026
Apr 7, 2026 12:20PM William Blair Downgrades Terns Pharmaceuticals (TERN) to Market Perform
Apr 6, 2026 12:41PM William Blair on Amgen (AMGN): top-line results show 'strong efficacy' compared to VRDN data
Apr 6, 2026 09:13AM Madison Air begins IPO roadshow for 82.7 million shares
Apr 6, 2026 09:12AM Madison Air Launches Roadshow for Proposed Initial Public Offering
Apr 6, 2026 06:01AM William Blair Starts WD-40 (WDFC) at Outperform
Apr 2, 2026 11:46AM William Blair on Acuity Brands (AYI): impressive margin beat, risk/reward skewed to upside
Apr 2, 2026 10:09AM William Blair on Tesla (TSLA): 'Big Miss in Energy Storage'
Apr 2, 2026 10:08AM William Blair Reiterates Market Perform Rating on Tesla (TSLA) after disappointing deliveries
Apr 1, 2026 02:49PM William Blair on James Hardie Industries (JHX): we anticipate more CBUSA type deals
Apr 1, 2026 12:46PM William Blair on MSC Industrial (MSM): cautious stance, MSM remains a 'show me' story
Apr 1, 2026 11:46AM William Blair on UniFirst Corp (UNF): shares muted despite beat, likely tied to Cintas deal
Apr 1, 2026 09:55AM William Blair on Avantor Inc. (AVTR): encouraging to see company make progress toward guide despite CFO departure
Apr 1, 2026 08:21AM William Blair stays Market Perform on Restoration Hardware (RH) amid guidance skepticism
Apr 1, 2026 07:15AM William Blair Shuffles Analyst Conviction List for April 2026
Apr 1, 2026 05:52AM William Blair on nCino Inc. (NCNO): 'AI May Disrupt Pockets of SaaS—but the Playbook Is Different in Banking'
Mar 31, 2026 03:28PM William Blair on Biogen (BIIB): 'we see potential to add $1.54 billion in sales' through APLS deal
Mar 31, 2026 03:19PM William Blair on Marvell (MRVL): Nvidia partnership, investment 'should help quell' questions of IP quality
Mar 31, 2026 03:16PM William Blair on Aehr Test Systems (AEHR): new order estimated at $10m, 'confirmatory of our thesis'
Mar 31, 2026 11:55AM William Blair Downgrades Apellis Pharmaceuticals (APLS) to Market Perform
Mar 31, 2026 06:16AM William Blair Starts MiniMed Group (MMED) at Outperform
Mar 30, 2026 05:42PM William Blair Upgrades 10X Genomics (TXG) to Outperform
Mar 30, 2026 01:01PM Form 497K WILLIAM BLAIR FUNDS
Mar 30, 2026 01:00PM Form 497 WILLIAM BLAIR FUNDS
Mar 30, 2026 10:19AM William Blair on Incyte (INCY): 'encouraged' by Ph3 data and deepened responses
Mar 30, 2026 09:50AM William Blair: 'we view BridgeBio as a core smidcap biotech holding'
Mar 27, 2026 04:45PM William Blair on Autolus Therapeutics plc (AUTL): LT blockbuster oppty despite YTD stock decline
Mar 27, 2026 03:30PM William Blair on Sterling Construction (STRL): shares outperforming on Meta El Paso data center news
Mar 27, 2026 09:49AM William Blair on ARS Pharmaceuticals Inc (SPRY): FDA label update 'viewed positively'
Mar 27, 2026 09:24AM William Blair on Kura Sushi USA Inc. (KRUS): 'expect a solid re-inflection into positive comps'
Mar 27, 2026 05:19AM William Blair Starts Nlight (LASR) at Outperform
Mar 26, 2026 05:57PM William Blair Reiterates Market Perform Rating on Enerpac Tool Group (EPAC) despite service biz weakness
Mar 26, 2026 04:06PM Wolfspeed completes $475.9 million refinancing with convertible notes
Mar 26, 2026 04:05PM Strategic Refinancing and New Equity Issuance Support Wolfspeed’s Long-term Growth Potential
Mar 26, 2026 03:10PM William Blair stays Outperform on AAR Corporation (AIR): sees 20% upside in next 12 months
Mar 26, 2026 11:07AM William Blair on Cintas (CTAS): expected to continue 'strong earnings growth'
Mar 26, 2026 10:56AM William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735
Mar 26, 2026 10:54AM William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive'
Mar 26, 2026 10:35AM Secondary Market Hits Record $220 Billion in 2025
Mar 26, 2026 09:21AM William Blair Reiterates Outperform Rating on MillerKnoll (MLKN) amid post-earnings selloff
Mar 26, 2026 08:48AM William Blair stays Outperform on Cardiff Oncology (CRDF) despite adoption hurdles, dilution risks
Mar 26, 2026 08:08AM William Blair stays Outperform rated on Karman Holdings Inc (KRMN) after solid earnings, guidance raise
Mar 26, 2026 07:43AM Adobe downgraded at William Blair on intensifying competitive pressure
Mar 26, 2026 04:37AM William Blair Downgrades Adobe (ADBE) to Market Perform
Mar 25, 2026 05:45PM William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'
Mar 25, 2026 05:40PM William Blair stays Market Perform on WillScot Holdings Corp (WSC) amid soft Feb. dodge starts
View More Recent Stories View Older Stories